Edwards Lifesciences has earned a gross profit of $253.1m for the third quarter ended 30 September 2010, compared to $227.2m for the same period in 2009.
Edwards Lifesciences’ has generated sales of $348.9m for the third quarter ended 30 September 2010, an increase of 7.1 %, compared to $325.7m for the same period in 2009.
The company has posted a net income of $48m for the third quarter 2010, or $0.40 per diluted share, compared to $73.5, or $0.63 per diluted share, for the comparable period in 2009.
For the nine months ended 30 September 2010, the company has posted a net income of $153.2m, or $1.29 per diluted share, compared to $181.5m, or $1.55 per diluted share, for the year ago period.
Edwards Lifesciences’ has reported sales of $1.05bn for the nine months ended 30 September 2010, compared to $974.7m for the year ago period.